![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/12/11/2794256/0/en/Third-Pole-Therapeutics-Announces-First-Patient-Dosed-in-Feasibility-Study-with-eNOfit-Portable-Inhaled-Nitric-Oxide-Delivery-System.html